Breaking News Instant updates and real-time market news.

FATE

Fate Therapeutics

$13.64 /

+0.07 (+0.52%)

10:49
12/08/19
12/08
10:49
12/08/19
10:49

Fate Therapeutics announces vivo preclinical data for FT596

Fate Therapeutics announced new in vivo preclinical data for FT596, its off-the-shelf, multi-antigen targeting natural killer cell product candidate derived from a clonal master engineered induced pluripotent stem cell line. The data were featured during the American Society of Hematology Meeting. New preclinical data showed that FT596 "administered as a monotherapy exhibited durable tumor clearance and extended survival in vivo similar to primary CAR T cells in a humanized mouse model of CD19+ lymphoma. Additionally, when combined with the anti-CD20 monoclonal antibody rituximab, FT596 showed enhanced killing of CD20+ lymphoma cells in vivo as compared to rituximab alone. These data confirm previously presented in vitro findings that demonstrate the unique multi-antigen targeting functionality of FT596, and the product candidate's potential to effectively overcome CD19 antigen escape," the company said. Fate also announced that, in preparation for Phase 1 initiation, it had recently completed GMP production of FT596. In a single small-scale manufacturing campaign, the company produced over 300 cryopreserved, infusion-ready doses of FT596 at a cost of approximately $2,500 per dose.

FATE Fate Therapeutics
$13.64 /

+0.07 (+0.52%)

11/06/19 WELS
Fate Therapeutics downgraded to Market Perform from Outperform at Wells Fargo
11/06/19 WELS
Wells Fargo downgrades Fate Therapeutics, cuts target to $16 from $24
11/06/19 MZHO
Mizuho backs Buy rating on Fate Therapeutics after competitor downgrade
11/12/19 RHCO
Fate Therapeutics initiated with a Buy at SunTrust

TODAY'S FREE FLY STORIES

Initiation
Ceridian initiated with an Overweight at Wells Fargo » 21:14
01/27/20
01/27
21:14
01/27/20
21:14
CDAY

Ceridian

$71.54 /

+ (+0.00%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Guidewire initiated with an Underweight at Wells Fargo » 21:09
01/27/20
01/27
21:09
01/27/20
21:09
GWRE

Guidewire

$111.51 /

-0.29 (-0.26%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Intuit initiated with an Equal Weight at Wells Fargo » 21:02
01/27/20
01/27
21:02
01/27/20
21:02
INTU

Intuit

$283.76 /

-4.41 (-1.53%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
RingCentral initiated with an Overweight at Wells Fargo » 20:57
01/27/20
01/27
20:57
01/27/20
20:57
RNG

RingCentral

$195.34 /

-2.07 (-1.05%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
M.D.C. Holdings raises quarterly dividend to 33c from 30c per share » 20:54
01/27/20
01/27
20:54
01/27/20
20:54
MDC

M.D.C. Holdings

$44.21 /

-0.11 (-0.25%)

The dividend will be paid…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Atlassian initiated with an Overweight at Wells Fargo » 20:50
01/27/20
01/27
20:50
01/27/20
20:50
TEAM

Atlassian

$143.95 /

-2.82 (-1.92%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Slack Technologies initiated with an Overweight at Wells Fargo » 20:45
01/27/20
01/27
20:45
01/27/20
20:45
WORK

Slack Technologies

$20.09 /

-0.505 (-2.45%)

, MSFT

Microsoft

$162.27 /

-2.76 (-1.67%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Anaplan initiated with an Overweight at Wells Fargo » 20:42
01/27/20
01/27
20:42
01/27/20
20:42
PLAN

Anaplan

$56.90 /

-1.17 (-2.01%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Portland General Electric initiated with a Sector Weight at KeyBanc » 20:34
01/27/20
01/27
20:34
01/27/20
20:34
POR

Portland General Electric

$60.60 /

+0.28 (+0.46%)

KeyBanc analyst Sophie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Twilio initiated with an Overweight at Wells Fargo » 20:33
01/27/20
01/27
20:33
01/27/20
20:33
TWLO

Twilio

$120.65 /

-0.84 (-0.69%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
First Mid-Illinois Bancshares downgraded to Neutral from Buy at DA Davidson » 20:31
01/27/20
01/27
20:31
01/27/20
20:31
FMBH

First Mid-Illinois Bancshares

$34.10 /

+0.08 (+0.24%)

DA Davidson analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
HubSpot initiated with an Equal Weight at Wells Fargo » 20:29
01/27/20
01/27
20:29
01/27/20
20:29
HUBS

HubSpot

$182.55 /

-1.74 (-0.94%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Inspire Medical initiated with an Underperform at Oppenheimer » 20:25
01/27/20
01/27
20:25
01/27/20
20:25
INSP

Inspire Medical

$78.50 /

-2.22 (-2.75%)

Oppenheimer analyst Suraj…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Earnings
Notable companies reporting before tomorrow's open » 20:25
01/27/20
01/27
20:25
01/27/20
20:25
PFE

Pfizer

$40.16 /

+0.34 (+0.85%)

, UTX

United Technologies

$151.12 /

-2.05 (-1.34%)

, LMT

Lockheed Martin

$432.31 /

-0.31 (-0.07%)

, MMM

3M

$175.70 /

-2.48 (-1.39%)

, HCA

HCA Healthcare

$141.57 /

-1.88 (-1.31%)

, PCAR

Paccar

$75.15 /

-1.64 (-2.14%)

, MKC

McCormick

$172.74 /

+0.005 (+0.00%)

, NUE

Nucor

$49.21 /

-1.13 (-2.24%)

, PHM

PulteGroup

$44.34 /

+0.62 (+1.42%)

, LEA

Lear

$130.47 /

-3.235 (-2.42%)

, AOS

A.O. Smith

$43.82 /

-1.63 (-3.59%)

, HOG

Harley-Davidson

$34.86 /

-0.37 (-1.05%)

, GPK

Graphic Packaging

$16.42 /

-0.01 (-0.06%)

, CIT

CIT Group

$45.02 /

-0.975 (-2.12%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Pfizer Inc. (PFE), consensus 57C... United Technologies (UTX), consensus $1.84... Lockheed Martin (LMT), consensus $5.02... 3M (MMM), consensus $2.10... HCA Healthcare (HCA), consensus $3.09... PACCAR (PCAR), consensus $1.51... McCormick (MKC), consensus $1.61... Nucor (NUE), consensus 31C... PulteGroup (PHM), consensus $1.09... Lear Corp. (LEA), consensus $2.20... A. O. Smith (AOS), consensus 59C... Harley-Davidson (HOG), consensus 9C... Graphic Packaging (GPK), consensus 23C... CIT Group (CIT), consensus $1.11.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Garmin upgraded to Neutral from Underperform at Credit Suisse » 20:15
01/27/20
01/27
20:15
01/27/20
20:15
GRMN

Garmin

$98.40 /

-1.17 (-1.18%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
SPDR Gold Shares holdings fall to 899.41MT from 900.58MT » 20:06
01/27/20
01/27
20:06
01/27/20
20:06
GLD

SPDR Gold Shares

$149.01 /

+1.05 (+0.71%)

This is the first decline…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Embraer, Boeing get approval for partnership from Brazil's CADE » 19:24
01/27/20
01/27
19:24
01/27/20
19:24
BA

Boeing

$316.61 /

-6.43 (-1.99%)

, ERJ

Embraer

$17.35 /

-0.485 (-2.72%)

Boeing (BA) and Embraer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Fly Intel: After Hours Movers » 18:57
01/27/20
01/27
18:57
01/27/20
18:57
GGG

Graco

$51.41 /

-0.605 (-1.16%)

, BRO

Brown & Brown

$41.70 /

-0.145 (-0.35%)

, IPAR

Inter Parfums

$70.67 /

-1.33 (-1.85%)

, XLRN

Acceleron

$52.83 /

+0.81 (+1.56%)

, SURF

Surface Oncology

$2.93 /

-0.13 (-4.25%)

, MNOV

MediciNova

$6.10 /

-0.26 (-4.09%)

, LAUR

Laureate Education

$17.70 /

+0.04 (+0.23%)

, FFIV

F5 Networks

$132.71 /

-3.14 (-2.31%)

, RMBS

Rambus

$14.57 /

-0.38 (-2.54%)

, JNPR

Juniper

$24.46 /

-0.12 (-0.49%)

, PKI

PerkinElmer

$98.74 /

-1.075 (-1.08%)

, JJSF

J & J Snack Foods

$184.54 /

-2.31 (-1.24%)

, ALEC

Alector

$25.72 /

+1.17 (+4.77%)

, DNLI

Denali Therapeutics

$27.97 /

+3.29 (+13.33%)

UP AFTER EARNINGS: Graco…

UP AFTER EARNINGS: Graco (GGG) up 4.6%... Brown&Brown (BRO) up 2.0%... Inter Parfums (IPAR) up 1.0%. ALSO HIGHER: Acceleron Pharma (XLRN) up 66.1% after announcing its sotatercept trial met endpoints... Surface Oncology (SURF) up 13.8% after getting FDA clearance for SRF617, SRF388 INDs... MediciNova (MNOV) up 11.3% after getting notice of intention to grant patent for MN-001 in Europe... Laureate Education (LAUR) up 4.5% after announcing plans to explore strategic alternatives. DOWN AFTER EARNINGS: F5 Networks (FFIV) down 4.5%... Rambus (RMBS) down 3.2%... Juniper (JNPR) down 2.9%... PerkinElmer (PKI) down 2.7%... J&J Snack Foods (JJSF) down 2.0%. ALSO LOWER: Alector (ALEC) down 2.8% after equity offering... Denali Therapeutics (DNLI) down 2.7% after equity offering. Movers as of 18:45ET.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29
    Jan
  • 30
    Jan
Hot Stocks
Intuit urges holders to reject mini-tender offer by TRC Capital » 18:50
01/27/20
01/27
18:50
01/27/20
18:50
INTU

Intuit

$283.76 /

-4.41 (-1.53%)

Intuit said it has been…

Intuit said it has been notified of an unsolicited mini-tender offer by TRC Capital Investment Corporation to purchase up to 400,000 shares of Intuit common stock at a price of $270.00 per share in cash. TRC's offer price is approximately 4.54 percent lower than the closing price of Intuit common stock on Jan. 17, 2020, the last trading day prior to the commencement of the offer, and approximately 6.28 percent lower than closing price of Intuit common stock on Jan. 24, 2020, the last trading day prior to this release. Intuit does not endorse TRC's offer and recommends that Intuit shareholders reject the offer and not tender their shares in response to TRC's unsolicited offer. The mini-tender offer is at a price below the market price of shares of Intuit's common stock (as of today's date) and is subject to numerous conditions, including TRC's ability to obtain financing. Intuit is not associated in any way with TRC, its mini-tender offer or the offer documentation. TRC has made many similar unsolicited mini-tender offers for shares of other publicly traded companies. Mini-tender offers seek to acquire less than 5 percent of a company's outstanding shares, thereby avoiding many disclosure and procedural requirements of the Securities and Exchange Commission that apply to tender offers for more than 5 percent of a company's outstanding shares. As a result, mini-tender offers may not provide investors with the same level of protections as provided in larger tender offers under U.S. securities laws, the company noted.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Ballard Power says now powers fuel cell EVs for 30M kilometers » 18:46
01/27/20
01/27
18:46
01/27/20
18:46
BLDP

Ballard Power

$9.14 /

-0.56 (-5.77%)

Ballard Power Systems…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Merit Medical confirms notice of Starboard director nominations » 18:21
01/27/20
01/27
18:21
01/27/20
18:21
MMSI

Merit Medical

$36.05 /

-0.55 (-1.50%)

Merit Medical Systems…

Merit Medical Systems confirmed that it has received notice from Starboard Value LP that it has nominated seven individuals to stand for election as directors at Merit's 2020 Annual Meeting of Shareholders. In its notice to Merit, Starboard indicated that it intends to withdraw four of its seven nominees if there are only three seats on Merit's Board to be filled at the Annual Meeting. The date of the Annual Meeting has not yet been set. Members of Merit's Board and management team recently had an initial discussion with representatives of Starboard, and Merit looks forward to further engagement to better understand Starboard's ideas. Merit values constructive input from all shareholders toward the shared goal of enhancing stakeholder value, the comapny said.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
MediciNova gets notice of intention to grant patent for MN-001 from EPO » 18:02
01/27/20
01/27
18:02
01/27/20
18:02
MNOV

MediciNova

$6.10 /

-0.26 (-4.09%)

MediciNov announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
JPMorgan to keep 2019 bonuses flat for traders, bankers, Bloomberg reports » 18:01
01/27/20
01/27
18:01
01/27/20
18:01
JPM

JPMorgan

$132.00 /

-1.14 (-0.86%)

JPMorgan is keeping…

JPMorgan is keeping annual bonuses at its corporate and investment bank approximately flat for 2019, Bloomberg's Michelle Davis reports. The company's decision, described by people briefed on the matter, came after the unit notched its best year since at least 2011. Most of the workers were told about their payouts last week, said one of the people. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
CBS says All Access achieved record month of sign-ups, TechCrunch says » 17:59
01/27/20
01/27
17:59
01/27/20
17:59
VIAC

ViacomCBS

$35.13 /

-0.65 (-1.82%)

, VIACA

ViacomCBS

$39.51 /

+0.4 (+1.02%)

CBS's streaming…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
U.S. FDA approves Trijardy XR for adults with type 2 diabetes » 17:38
01/27/20
01/27
17:38
01/27/20
17:38
LLY

Eli Lilly

$138.38 /

-0.71 (-0.51%)

The U.S. FDA has approved…

The U.S. FDA has approved Trijardy XR to lower blood sugar in adults with type 2 diabetes, along with diet and exercise. Trijardy XR provides three type 2 diabetes medicines in one pill, including Jardiance, Tradjenta, and metformin hydrochloride extended release. Trijardy XR is marketed by Boehringer Ingelheim Pharmaceuticals and Eli Lilly and Company.

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.